Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $838.50M | $823.40M | $977.20M | $860.50M | $797.40M | $801.40M | $979.60M | $864.40M |
| Cost of revenue | $422.50M | $443.60M | $528.00M | $481.10M | $439.50M | $410.20M | $486.30M | $445.60M |
| Gross profit | $416.00M | $379.80M | $449.20M | $379.40M | $357.90M | $391.20M | $493.30M | $418.80M |
| Gross margin | 49.6% | 46.1% | 46.0% | 44.1% | 44.9% | 48.8% | 50.4% | 48.4% |
| Research and development | $94.30M | $101.30M | $99.60M | $98.30M | $100.20M | $97.10M | $104.40M | $98.10M |
| Selling, general and administrative | $238.90M | $242.10M | $247.20M | $242.50M | $231.40M | $225.40M | $247.30M | $229.90M |
| Operating expenses | $481.30M | $369.60M | $372.90M | $431.20M | $346.00M | $359.40M | $421.20M | $350.70M |
| Operating income | −$65.30M | $10.20M | $76.30M | −$51.80M | $11.90M | $31.80M | $72.10M | $68.10M |
| Operating margin | -7.8% | 1.2% | 7.8% | -6.0% | 1.5% | 4.0% | 7.4% | 7.9% |
| EBITDA | $127.60M | $68.50M | $134.40M | $100.40M | $68.00M | $82.20M | $125.00M | $119.10M |
| Interest income | $11.30M | $0 | $0 | — | $2.70M | $0 | $0 | — |
| Interest expense | −$17.80M | $0 | $0 | — | −$15.70M | $0 | $0 | — |
| Income before taxes | −$40.70M | $21.90M | $68.20M | −$71.80M | $500.00K | $25.10M | $56.10M | $55.30M |
| Income taxes | $14.20M | $2.50M | $37.80M | −$14.10M | −$3.10M | $8.70M | $40.70M | $14.80M |
| Net income | −$50.90M | $15.70M | $29.20M | −$58.50M | $4.20M | $16.80M | $13.90M | $40.30M |
| Net margin | -6.1% | 1.9% | 3.0% | -6.8% | 0.5% | 2.1% | 1.4% | 4.7% |
| EPS, basic | −$0.41 | $0.02 | $0.10 | −$0.41 | $0.05 | $0.11 | $0.09 | $0.27 |
| EPS, diluted | −$0.41 | $0.02 | $0.10 | −$0.41 | $0.05 | $0.11 | $0.09 | $0.27 |
| Diluted shares | 152.30M | 152.70M | 151.80M | 151.80M | 151.70M | 151.90M | 152.10M | 152.00M |
Figures describe Bruker shares, not any token. As of Aug 5, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.